Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · ICU Medical (ICUI)

ICU Medical director William Seeger resigns from board, effective immediately

Neutral Impact 2 of 5 leadership Written later

William Seeger, a director of ICU Medical, resigned from the company's board and its Audit and Compliance Committee effective immediately, as Smiths Group's nominated director, in anticipation of his retirement from the Smiths Group board on May 31, 2024. The filing states the resignation did not result from any disagreement with the company or any matter relating to its operations, policies or practices, and that Smiths Group keeps the right to designate a board member while it owns at least 5% of the company's common stock.

Key points

  • William Seeger resigned from the ICU Medical board and Audit and Compliance Committee, effective immediately
  • Seeger's resignation is tied to his planned retirement from the Smiths Group plc board on May 31, 2024
  • The filing states no disagreement with the company or matter relating to its operations, policies or practices
  • Smiths Group may keep designating a board member while it owns at least 5% of ICU Medical common stock, per the January 6, 2022 Shareholders Agreement

The filing

CompanyICU Medical (ICUI)
Form8-K, current report
Filed with the SECFeb 29, 2024, 8:32 AM ET
Accession number0000883984-24-000007

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:01 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 29, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.